Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR7 | P34969 | 5/20 | 0.39 |
| ▸ | ADRA1D | P25100 | 2/20 | 0.39 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.39 |
| ▸ | ADRA1B | P35368 | 2/20 | 0.39 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.32 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.31 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.31 |
| ▸ | ABL1 | P00519 | 1/20 | 0.30 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7948892 | 0.92 | HTR7 (0.36) | HTR7ADRA1DADRA1AADRA1BCARM1 | |
| SCHEMBL9240771 | 0.84 | ADRB2 (0.40) | HTR7ADRA1DADRA1AADRA1BLMNA | |
| SCHEMBL9066422 | 0.84 | DCPS (0.39) | HTR7ADRA1DADRA1AADRA1BLMNA | |
| SCHEMBL29352185 | 0.83 | HTR7 (0.33) | HTR7ADRA1DADRA1AADRA1BLMNA | |
| SCHEMBL22188696 | 0.83 | HTR7 (0.33) | HTR7ADRA1DADRA1AADRA1BLMNA | |
| SCHEMBL117903 | 0.83 | HTR7 (0.33) | HTR7ADRA1DADRA1AADRA1BLMNA | |
| Bromomethane SCHEMBL3305907 | 0.81 | HTR7 (0.32) | HTR7ADRA1DADRA1AADRA1BLMNA | |
| SCHEMBL27605123 | 0.81 | LMNA (0.36) | HTR7ADRA1DADRA1AADRA1BLMNA | |
| SCHEMBL3433849 | 0.81 | LMNA (0.40) | HTR7ADRA1DADRA1AADRA1BLMNA | |
| SCHEMBL7116723 | 0.81 | HTR7 (0.35) | HTR7ADRA1DADRA1AADRA1BLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1893016-B1 | WATER-IN-OIL SUSPOEMULSIONS | BAYER IP GMBH (DE) | 2017-09-13 | — | — | EP | disclosed |
| EP-1651039-B1 | OIL SUSPENSION CONCENTRATE CONTAINING DIFLUFENICAN | BAYER IP GMBH (DE) | 2017-01-04 | — | — | EP | disclosed |
| EP-1928232-B1 | SOLID FORMULATION | BAYER IP GMBH (DE) | 2016-07-13 | — | — | EP | disclosed |
| EP-1571908-B1 | OIL SUSPENSION CONCENTRATE | BAYER CROPSCIENCE AG (DE) | 2014-12-17 | — | — | EP | disclosed |
| US-8198214-B2 | Solid formulation | BAYER CROPSCIENCE AG (DE) | 2012-06-12 | — | — | US | disclosed |
| US-8198214-B2 | Solid formulation | BAYER CROPSCIENCE AG (DE) | 2012-06-12 | — | — | US | disclosed |
| US-8158557-B2 | Storage-stable formulations of sulfonamides | BAYER CROPSCIENCE AG (DE) | 2012-04-17 | — | — | US | disclosed |
| US-8158557-B2 | Storage-stable formulations of sulfonamides | BAYER CROPSCIENCE AG (DE) | 2012-04-17 | — | — | US | disclosed |
| US-20110152082-A1 | LIQUID FORMULATIONS | BAYER CROPSCIENCE AG (DE) | 2011-06-23 | — | — | US | disclosed |
| US-20110152082-A1 | LIQUID FORMULATIONS | BAYER CROPSCIENCE AG (DE) | 2011-06-23 | — | — | US | disclosed |
| US-20070066487-A1 | Solid formulation | BAYER CROPSCIENCE GMBH (DE) | 2007-03-22 | — | — | US | disclosed |
| WO-2007028504-A2 | NOVEL SULFONAMIDE-CONTAINING SOLID FORMULATIONS | BAYER CROPSCIENCE AG (DE) | 2007-03-15 | — | — | WO | disclosed |
| WO-2007028529-A1 | STORAGE-STABLE SULPHONAMIDE FORMULATIONS | BAYER CROPSCIENCE AG (DE) | 2007-03-15 | — | — | WO | disclosed |
| WO-2007028505-A2 | NOVEL SULFONAMIDE-CONTAINING SOLID FORMULATIONS | BAYER CROPSCIENCE AG (DE) | 2007-03-15 | — | — | WO | disclosed |
| US-20070054807-A1 | Storage-stable formulations of sulfonamides | BAYER CROPSCIENCE GMBH (DE) | 2007-03-08 | — | — | US | disclosed |
| US-20070054807-A1 | Storage-stable formulations of sulfonamides | BAYER CROPSCIENCE GMBH (DE) | 2007-03-08 | — | — | US | disclosed |
| US-20070054805-A1 | Novel sulfonamide-comprising solid formulations | BAYER CROPSCIENCE GMBH (DE) | 2007-03-08 | — | — | US | disclosed |
| US-20070054805-A1 | Novel sulfonamide-comprising solid formulations | BAYER CROPSCIENCE GMBH (DE) | 2007-03-08 | — | — | US | disclosed |
| US-20070054806-A1 | Novel sulfonamide-comprising solid formulations | BAYER CROPSCIENCE GMBH (DE) | 2007-03-08 | — | — | US | disclosed |
| US-20070054806-A1 | Novel sulfonamide-comprising solid formulations | BAYER CROPSCIENCE GMBH (DE) | 2007-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070054806-A1 | Novel sulfonamide-comprising solid formulations | SULT2A1, ARSA, SLC43A1 | HTR7 4474/4885ADRA1D 3890/4885ADRA1A 3595/4885 |
| US-20070054805-A1 | Novel sulfonamide-comprising solid formulations | SULT2A1, ARSA, SLC43A1 | HTR7 4543/4885ADRA1D 3890/4885ADRA1A 3603/4885 |
| US-20070066487-A1 | Solid formulation | SMS, SRM, STS | HTR7 3130/4885ADRA1D 4373/4885ADRA1A 4559/4885 |
| US-20110152082-A1 | LIQUID FORMULATIONS | CBX3, CBX6, IPO11 | HTR7 3012/4885ADRA1D 3734/4885ADRA1A 4118/4885 |
| US-20070054807-A1 | Storage-stable formulations of sulfonamides | STS, ARSA, SMS | HTR7 3155/4885ADRA1D 4789/4885ADRA1A 4780/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.